Skip to main content
. 2024 Dec 23;3(12):e0000698. doi: 10.1371/journal.pdig.0000698

Table 1. Overall demographics and clinical characteristics (n = 99).

ASCVD = Atherosclerotic Cardiovascular Disease, BAC = Breast artery calcification, CAC = coronary artery calcification, MACE = Major Adverse Cardiac Events. *ASCVD risk score was incalculable for 11 patients due to data outside the allowable thresholds.

Variable Category Count (%)
Age 40–49 6 (6.06%)
50–59 16 (16.16%)
60–69 30 (30.30%)
70 and over 47 (47.47%)
Race White 68 (68.69%)
Black/ African American 16 (16.16%)
Hispanic/Latino 12 (12.12%)
Other 3 (3.03%)
BAC Positive 49 (49.49%)
Negative 50 (50.51%)
CAC Positive 37 (37.37%)
Negative 62 (62.63%)
ASCVD risk score * Low risk (<5%) 22 (25.0%)
Borderline risk (5%-7.4%) 7 (7.95%)
Intermediate risk (7.5%-19.9%) 30 (34.09%)
High risk (>20%) 29 (32.95%)
ASCVD risk score* (binary) Low risk (<7.5%) 29 (32.95%)
Moderate–High risk (7.5%—over 20%) 59 (67.05%)
MACE Yes 26 (26.26%)
No 73 (73.74%)
Death Yes 16 (16.16%)
No 83 (83.84%)
Smoking Status Never 57 (57.58%)
Current 38 (38.38%)
Unknown 4 (4.04%)
Diabetes Yes 20 (20.20%)
No 79 (79.80%)
Hypertension Yes 58 (58.58%)
No 41 (41.41%)